NCT01349413View on ClinicalTrials.gov

BRAVO Study for Functional Dyspepsia

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

August 24, 2011

Primary Completion Date

December 30, 2017

Study Completion Date

July 19, 2018

Conditions
DyspepsiaGastroesophageal Reflux
Interventions
DRUG

Esomeprazole 20mg

Oral Esomeprazole 20mg daily for 8 weeks

OTHER

Placebo

Identical looking placebo

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT01349413 - BRAVO Study for Functional Dyspepsia | Biotech Hunter | Biotech Hunter